Biodimension
Human-relevant tissue models for testingBiodimension revenue, valuation and funding
It has raised ₹8 crore in total, as reported by StopDown on 11 June 2026.
| Total raised | ₹8 crore |
|---|
Each figure links to the story that reported it.
Biodimension key facts
- What it doesHuman-relevant tissue models for testing Story
- Founded2021 Profile
- HeadquartersBengaluru
- Last round₹8 Cr, on 11 June 2026 Story
- StatusPrivate
Funding rounds
| When | Round | Amount | Investors | Source |
|---|---|---|---|---|
| Jun 2026 | Angel round | ₹8 crore | IAN Angel Fund (lead), Campus Angels Network, Dr. Sampath Srisailam, Aaryan Baid | SiliconIndia |
Timeline
- 2021
- 2021 Biodimension starts in Bengaluru Indian Startup Times
- 2026
- Jun 2026 Raises ₹8 crore led by IAN Angel Fund SiliconIndia
The short version
- Biodimension, a Bengaluru life-sciences startup, grows human tissue and organ models for drug and cosmetics testing. SiliconIndiaIndian Startup Times
- Manojkumar S. (CEO), Ranjith Kumar Velusamy and Pradeep Arunachalam are the co-founders. SiliconIndiaIndian Startup Times
- It grows human cells on biomaterial scaffolds to make skin models and miniature organs. Indian Startup Times
- In Jun 2026 it raised ₹8 crore in a round led by IAN Angel Fund. SiliconIndia
- It plans to grow its cancer biobank and an on-demand testing service. SiliconIndia
Products
- Tissue models: Reconstructed human skin and organoids, used to test drugs and cosmetics without animals. The facility is about 6,000 sq ft. Indian Startup Times
People
- Manojkumar S.: Co-founder and CEO. SiliconIndia
- Ranjith Kumar Velusamy: Co-founder. SiliconIndiaIndian Startup Times
- Pradeep Arunachalam: Co-founder. SiliconIndiaIndian Startup Times
Questions people ask about Biodimension
What does Biodimension do?
Biodimension, based in Bengaluru, makes lab-grown human tissues and organoids that drug and cosmetics makers can use in place of animal tests. It grows human cells on biomaterial scaffolds to build skin models and small organs. Indian Startup Times
How much has Biodimension raised?
Biodimension raised ₹8 crore in Jun 2026 in a round led by IAN Angel Fund, with Campus Angels Network and angel investors Dr. Sampath Srisailam and Aaryan Baid. No earlier round appears in the coverage we read. SiliconIndia
Every line links to the article it came from, written in our own words. Not investment advice. Profile updated 2026-11-15.
Stories cover its news and funding. Sectors: Healthcare & Life Sciences. Based in Bengaluru. Stories run from 11 June 2026 to 29 August 2026.
The founders
Manokumar
Founder- Studied biotechnology at VIT (Vellore Institute of Technology).
- Has industry experience before founding Biodimension.
Ranjith Kumar Velusamy
Co-founder- Studied biotechnology at VIT.
Pradeep Arunachalam
Co-founder- Studied biotechnology at VIT.
Who put in money
Every story on Biodimension
- BIBiodimension · News · 29 August 2026Biodimension builds human tissue alternatives to animal testingBiodimension makes reconstructed human tissues and organoids for drug discovery and cosmetics testing
- BIBiodimension · Funding · 11 June 2026 · ₹8 CrBiodimension raises ₹8 crore from IAN Angel FundBiodimension makes lab-grown human tissue and organ models that replace animal testing
Read next on Biodimension
For Biodimension: add the “Featured on StopDown” badge
Put this on your website's press or media page. It links readers to Biodimension on StopDown.

